Why Eli Lilly Stock Popped on Thursday

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report.Heading into the report, analysts forecast Lilly would earn $5.08 per share on sales of $13.4 billion. As it turns out, Lilly earned $5.32 per share in Q4, and sales were $13.5 billion. Driven by strong demand for its Mounjaro and Zepbound GLP-1 drugs, Lilly grew its Q4 sales 45% year over year. But sales of non GLP-1 drugs (which Lilly refers to as "non-incretin") weren't too shabby either, growing 20%.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool